A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
about
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyDifferent dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyGranulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerRandomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma.Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancerThe use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerHaematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerWeekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerPhase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.Current status of epirubicin (Farmorubicin) in the treatment of solid tumours.How to improve cytotoxic therapy in advanced breast cancer.High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer.Autologous stem cell transplantation in breast cancer."First do no harm" and the importance of prediction in oncology.Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF).Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.
P2860
Q24240568-96AFED09-0591-4A0E-AB97-6A074071FEC7Q24243810-BDEC47A8-14B8-4896-BC61-A462BAA5CE9BQ28378467-092D61C4-4F20-4013-8EBA-0B6402BF750CQ33348421-F3C7AE2E-7BE6-4254-8A0D-B0856A44D829Q35095352-58625AD2-340B-4B17-A432-D9D00DB7B656Q35976530-922AF237-B535-479E-AB8D-612F3B3DB2EEQ36080547-BDB706CC-A215-4E75-B9CB-5C4173F44A3FQ36115998-964AD6BB-D4BC-472A-9CB7-440A5509F7D6Q36467864-DD916C69-CF06-4126-BD89-109389A9E1EAQ36468076-C0F55D2F-F121-4712-864F-400CC06EC5F7Q36646250-FD0147A7-53B3-4C83-AD4A-7ED5E9C7597CQ37344525-D5793E0D-F883-4C73-B6BA-849AA5B8B483Q37938298-0EBDEEC6-F9EE-4944-831C-D7027A325A08Q37938316-B364CC94-DADE-4E7F-8EE9-B88397DB9731Q40800322-4939AADB-1349-4E1B-ADC0-670610B7BE64Q40958165-B10E2CB7-F907-4468-B7C0-168585E3E5DEQ41056692-90A4BBE6-0F52-472E-8F54-6BD2A32413A3Q41731147-F44064C0-4E14-4667-B567-0B52A1F7AC52Q44949591-6DDB7529-4C0F-4C28-BD7F-32D1EA8C04D4Q53195496-D88CD667-69A1-4457-B133-9955B19CF966
P2860
A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
A comparison of two doses of a ...... disseminated breast carcinoma.
@ast
A comparison of two doses of a ...... disseminated breast carcinoma.
@en
type
label
A comparison of two doses of a ...... disseminated breast carcinoma.
@ast
A comparison of two doses of a ...... disseminated breast carcinoma.
@en
prefLabel
A comparison of two doses of a ...... disseminated breast carcinoma.
@ast
A comparison of two doses of a ...... disseminated breast carcinoma.
@en
P2093
P2860
P356
P1476
A comparison of two doses of a ...... disseminated breast carcinoma.
@en
P2093
Cantinho-Lopes MG
Carmo-Pereira J
Henriques E
Sales-Luis A
P2860
P2888
P304
P356
10.1038/BJC.1987.226
P407
P577
1987-10-01T00:00:00Z